Atherectomy Devices Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Atherectomy devices are catheter-based tools designed to debulk calcified or fibrotic plaque from arteries, frequently used as an adjunct or alternative to balloon angioplasty and stenting. The global market was worth around $1.03 billion in 2025 and is expected to grow steadily, reaching roughly $1.5 billion by the early 2030s on a 7.38% CAGR. North America currently represents the largest regional segment, while Asia-Pacific is emerging as the fastest-growing geography.

• •Global market valued at approximately USD 1.03 billion in 2025
• •Forecast CAGR of 7.38% through the early 2030s
• •North America holds the leading share, with Asia-Pacific expanding the fastest

The principal growth engine is the rising global burden of cardiovascular disease (CVD) and peripheral artery disease (PAD), particularly among adults over 65. Technological refinement, including improved catheter flexibility, real-time imaging integration, and devices tailored for severely calcified lesions, is broadening clinical indications. Favorable reimbursement pathways in developed markets and the continued migration from open surgery to minimally invasive endovascular procedures are also reinforcing adoption.

• •Increasing prevalence of PAD, CAD, and calcified lesions in aging populations
• •Advances in rotational, orbital, and laser catheter designs improving safety and efficacy
• •Expanding reimbursement coverage for outpatient endovascular interventions

By product, the market is generally divided into rotational, directional, orbital, and laser atherectomy systems, with rotational and orbital systems typically accounting for the largest revenue share. Application segments include peripheral vascular and coronary interventions, where peripheral vascular procedures currently dominate due to the high volume of PAD treatments. Geographically, the United States drives most revenue, supported by established procedural volumes and reimbursement, while Germany, Japan, China, and India represent the most active non-U.S. markets.

• •Rotational and orbital atherectomy devices lead by product share
• •Peripheral vascular applications exceed coronary in current procedural volume
• •U.S. contributes the largest national share, with Asia-Pacific posting the highest growth rate

What are the recent trends and outlook?

Near-term trends include the development of combined atherectomy-and-drug-coated-balloon workflows, improved imaging guidance, and devices engineered for increasingly complex calcified lesions. Clinical evidence supporting atherectomy in specific lesion subsets, particularly heavily calcified femoropopliteal disease, continues to shape adoption. Looking ahead, the market is expected to sustain mid-to-high single-digit growth as PAD prevalence rises and minimally invasive therapies replace more invasive surgical options.

• •Growing integration of atherectomy with drug-coated balloon and intravascular imaging strategies
• •Strongest expansion expected in Asia-Pacific and other emerging healthcare markets
• •Long-term outlook remains positive, supported by demographic and endovascular procedural trends